デフォルト表紙
市場調査レポート
商品コード
1433605

カンナビジオールの市場規模、シェア、動向分析レポート:原料タイプ別、販売タイプ別、最終用途別、地域別、セグメント別予測、2024年~2030年

Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End-use (Medical, Personal Use), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
カンナビジオールの市場規模、シェア、動向分析レポート:原料タイプ別、販売タイプ別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年01月12日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

カンナビジオール市場の成長と動向:

Grand View Research, Inc.の新しい調査によると、世界のカンナビジオール市場規模は2030年までに220億5,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 15.8%で拡大する見込みです。CBD製品に対する消費者の態度の変化、世論の変化、カンナビジオールの健康効果に対する認識の高まりが、市場成長の主な要因の一部です。大麻サティバ植物には80種類以上のカンナビノイドが含まれていますが、カンナビジオールは精神作用がないため、医療目的で最も広く使用されています。CBD含有量が高いため、主に麻から得られます。

美容製品、カンナビスオイル、飲料、グミ、カプセルなど、さまざまなCBD入り製品の需要が高いです。CBDは、ベイプ、喫煙、経皮など、さまざまな手段で人体に入ることができます。大麻が合法である米国では、CBDはパーソナルケア製品や医療用医薬品の製造に利用されています。大麻ベースの製品が合法化されたことで、様々な最終用途産業が製品の提供を拡大する大きな機会が生まれました。

業界の大手企業はCBD入り製品の導入に注力しています。CBDの需要が世界的に高まる中、企業は国際市場でのビジネスチャンスを模索しています。さらに、製品の有効性と効率を高め、提供する製品を拡大するために研究開発に投資しています。プレーヤーは、需要の増加に対応するために、エディブル、外用薬、飲料などの新しく革新的な製品を導入しています。例えば、2022年5月、Medical Marijuana, Inc.は、薬局でのCBD製品へのアクセスを拡大するため、ブラジルで「HM Pharma」と名付けた製薬子会社の立ち上げを発表しました。

カンナビジオール市場レポートハイライト

  • 北米は主要メーカーの存在により2023年の市場シェア87.4%で最大を占め、米国農業法案の承認が同地域の成長を促進する主な要因のいくつかです。
  • 麻由来のCBDは、その高い純度と潜在的な健康効果により、2023年の市場シェアを独占しました。
  • 2023年には、需要の増加とカンナビジオールを原料として使用する企業の増加により、B2B分野が最大の市場シェアを占めます。
  • 2023年には、様々な病状に対する大麻誘導体の使用増加により、医薬品セグメントが最終用途市場で最大の市場シェアを占めました。

目次

第1章 カンナビジオール市場:調査手法と範囲

第2章 カンナビジオール市場:エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察

第3章 カンナビジオール市場:変数、動向、範囲

  • 市場系統の見通し
  • 国別の大麻規制シナリオ
  • 市場力学
  • カンナビジオール市場分析ツール
  • 国別の輸出入シナリオ

第4章 カンナビジオール市場:原料タイプの推定・動向分析

  • 原料タイプの市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 原料タイプ別の世界のカンナビジオール市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第5章 カンナビジオール市場:販売タイプの推定・動向分析

  • 販売タイプの市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 販売タイプ別の世界のカンナビジオール市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第6章 カンナビジオール市場:最終用途の推定・動向分析

  • 最終用途の市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界のカンナビジオール市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第7章 カンナビジオール市場:地域の推定・動向分析

  • 地域の市場シェア分析、2023年および2030年
  • 地域の市場ダッシュボード
  • 世界の地域市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年まで
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スイス
    • オランダ
    • ポーランド
    • チェコ共和国
    • クロアチア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • ニュージーランド
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • ウルグアイ
    • チリ
  • 中東・アフリカ
    • 南アフリカ
    • イスラエル

第8章 競合情勢

  • 最近の動向と影響分析:主要市場参入企業別
  • 会社/競合の分類
  • ベンダー情勢
    • ENDOCA
    • Cannoid, LLC
    • Medical Marijuana, Inc.
    • Folium Europe BV
    • Canopy Growth Corporation
    • Elixinol
    • NuLeaf Naturals, LLC
    • Isodiol International, Inc.
    • PharmaHemp
    • The Cronos Group
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 4 North America cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 5 North America cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 7 U.S. cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 8 U.S. cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 10 Canada cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 11 Canada cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 14 Europe cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 15 Europe cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 17 Germany cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 18 Germany cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 20 UK cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 21 UK cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 23 France cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 24 France cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 26 Italy cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 27 Italy cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Switzerland cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 29 Switzerland cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 30 Switzerland cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Poland cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 32 Poland cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 33 Poland cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 34 The Netherlands cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 35 The Netherlands cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 36 The Netherlands cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Czech Republic cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 38 Czech Republic cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 39 Czech Republic cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Croatia cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 41 Croatia cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 42 Croatia cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 48 China cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 49 China cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 51 Japan cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 52 Japan cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 54 India cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 55 India cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 57 South Korea cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 58 South Korea cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 60 Australia cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 61 Australia cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 62 New Zealand cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 63 New Zealand cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 64 New Zealand cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 66 Latin America cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 67 Latin America cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 69 Brazil cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 70 Brazil cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Mexico cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 72 Mexico cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 73 Mexico cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Argentina cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 75 Argentina cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 76 Argentina cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Colombia cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 78 Colombia cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 79 Colombia cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Uruguay cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 81 Uruguay cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 82 Uruguay cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Chile cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 84 Chile cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 85 Chile cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 86 MEA cannabidiol market, by region, 2018 - 2030 (USD Million)
  • Table 87 MEA cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 88 MEA cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 89 MEA cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 90 South Africa cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 91 South Africa cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 92 South Africa cannabidiol market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Israel cannabidiol market, by source type, 2018 - 2030 (USD Million)
  • Table 94 Israel cannabidiol market, by sales type, 2018 - 2030 (USD Million)
  • Table 95 Israel cannabidiol market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cannabidiol market: market outlook
  • Fig. 9 Cannabidiol competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cannabidiol market driver impact
  • Fig. 15 Cannabidiol market restraint impact
  • Fig. 16 Cannabidiol market strategic initiatives analysis
  • Fig. 17 Cannabidiol market: Source type movement analysis
  • Fig. 18 Cannabidiol market: Source type outlook and key takeaways
  • Fig. 19 Hemp market estimates and forecast, 2018 - 2030
  • Fig. 20 Marijuana market estimates and forecast, 2018 - 2030
  • Fig. 21 Cannabidiol Market: Sales type movement Analysis
  • Fig. 22 Cannabidiol market: Sales type outlook and key takeaways
  • Fig. 23 Business to Business (B2B) market estimates and forecasts, 2018 - 2030
  • Fig. 24 Business to Business (B2C) market estimates and forecasts,2018 - 2030
  • Fig. 25 Hospital pharmacies market estimates and forecasts,2018 - 2030
  • Fig. 26 Online stores market estimates and forecasts,2018 - 2030
  • Fig. 27 Retail pharmacies market estimates and forecasts,2018 - 2030
  • Fig. 28 Cannabidiol market: end use movement analysis
  • Fig. 29 Cannabidiol market: end use outlook and key takeaways
  • Fig. 30 Medical use market estimates and forecasts, 2018 - 2030
  • Fig. 31 Chronic pain market estimates and forecasts,2018 - 2030
  • Fig. 32 Mental disorders market estimates and forecasts, 2018 - 2030
  • Fig. 33 Cancer market estimates and forecasts,2018 - 2030
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030
  • Fig. 35 Personal use market estimates and forecasts,2018 - 2030
  • Fig. 36 Pharmaceutical CBD market estimates and forecasts,2018 - 2030
  • Fig. 37 Wellness market estimates and forecasts,2018 - 2030
  • Fig. 38 Food & beverages market estimates and forecasts,2018 - 2030
  • Fig. 39 Personal care & cosmetics market estimates and forecasts,2018 - 2030
  • Fig. 40 Nutraceuticals market estimates and forecasts,2018 - 2030
  • Fig. 41 Others end use market estimates and forecasts,2018 - 2030
  • Fig. 42 Global cannabidiol market: Regional movement analysis
  • Fig. 43 Global cannabidiol market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 50 France market estimates and forecasts, 2018 - 2030
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 52 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 53 Poland market estimates and forecasts, 2018 - 2030
  • Fig. 54 Czech Republic market estimates and forecasts, 2018 - 2030
  • Fig. 55 Croatia market estimates and forecasts, 2018 - 2030
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 57 China market estimates and forecasts, 2018 - 2030
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 59 India market estimates and forecasts, 2018 - 2030
  • Fig. 60 New Zealand market estimates and forecasts, 2018 - 2030
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 65 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 67 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 68 Uruguay market estimates and forecasts, 2018 - 2030
  • Fig. 69 Chile market estimates and forecasts, 2018 - 2030
  • Fig. 70 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 72 Israel market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-3-68038-122-1

Cannabidiol Market Growth & Trends:

The global cannabidiol market size is expected to reach USD 22.05 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2024 to 2030. Changing consumer attitudes towards CBD products, shifting public opinion, and growing recognition of the health benefits of cannabidiol are some of the main factors contributing to the market's growth. The cannabis Sativa plant contains more than 80 cannabinoids, but cannabidiol is the most widely used for medical purposes because of its lack of psychoactive effects. It is primarily obtained from hemp due to its high CBD content.

There is a high demand for various CBD-infused products, such as beauty products, cannabis oil, beverages, gummies, capsules, etc. CBD can enter the human body through different means, including vaping, smoking, and through the skin. In the U.S., where cannabis is legal, CBD is utilized to produce personal care products and medical drugs. Legalizing cannabis-based products has opened up significant opportunities for various end-use industries to expand their product offerings.

Major players in the industry are focused on introducing CBD-infused products. Companies are exploring opportunities in international markets as the demand for CBD grows globally. Furthermore, they are investing in research and development to enhance the effectiveness and efficiency of their products, as well as to expand their offerings. The players are introducing new and innovative products, such as edibles, topicals, and beverages, to cater to the growing demand. For instance, in May 2022, Medical Marijuana, Inc. announced the launch of a pharma subsidiary in Brazil named "HM Pharma" to expand its access to CBD products in pharmacies.

Cannabidiol Market Report Highlights:

  • North America accounts for the largest with a market share of 87.4% in 2023 owing to the presence of major manufacturers, and approval of the U.S. Farm Bill are some of the major factors driving the growth of the region
  • Hemp-derived CBD dominated the market in 2023, with a market share owing to its higher purity and potential health benefits
  • B2B segment accounts for the largest market share in 2023 owing to increasing demand and a rising number of businesses using cannabidiol as raw materials
  • In 2023, the pharmaceuticals segment accounted for the largest market share in the end-use market owing to rising use of cannabis derivate for various medical conditions

Table of Contents

Chapter 1. Cannabidiol Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source type
    • 1.2.2. Sales type
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Cannabidiol Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Source type outlook
    • 2.2.2. Sales type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cannabidiol Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Cannabis Regulatory Scenario, By Country
    • 3.2.1. U.S.
      • 3.2.1.1. Cultivation/Production
      • 3.2.1.2. Legal Status (CBD & THC)
      • 3.2.1.3. Regulatory Bodies Involved
    • 3.2.2. Canada
      • 3.2.2.1. Cultivation/Production
      • 3.2.2.2. Legal Status (CBD & THC)
      • 3.2.2.3. Regulatory Bodies Involved
    • 3.2.3. Germany
      • 3.2.3.1. Cultivation/Production
      • 3.2.3.2. Legal Status (CBD & THC)
      • 3.2.3.3. Regulatory Bodies Involved
    • 3.2.4. Italy
      • 3.2.4.1. Cultivation/Production
      • 3.2.4.2. Legal Status (CBD & THC)
      • 3.2.4.3. Regulatory Bodies Involved
    • 3.2.5. Croatia
      • 3.2.5.1. Cultivation/Production
      • 3.2.5.2. Legal Status (CBD & THC)
      • 3.2.5.3. Regulatory Bodies Involved
    • 3.2.6. Netherlands
      • 3.2.6.1. Cultivation/Production
      • 3.2.6.2. Legal Status (CBD & THC)
      • 3.2.6.3. Regulatory Bodies Involved
    • 3.2.7. Czech Republic
      • 3.2.7.1. Cultivation/Production
      • 3.2.7.2. Legal Status (CBD & THC)
      • 3.2.7.3. Regulatory Bodies Involved
    • 3.2.8. Poland
      • 3.2.8.1. Cultivation/Production
      • 3.2.8.2. Legal Status (CBD & THC)
      • 3.2.8.3. Regulatory Bodies Involved
    • 3.2.9. Switzerland
      • 3.2.9.1. Cultivation/Production
      • 3.2.9.2. Legal Status (CBD & THC)
      • 3.2.9.3. Regulatory Bodies Involved
    • 3.2.10. Australia
      • 3.2.10.1. Cultivation/Production
      • 3.2.10.2. Legal Status (CBD & THC)
      • 3.2.10.3. Regulatory Bodies Involved
    • 3.2.11. Israel
      • 3.2.11.1. Cultivation/Production
      • 3.2.11.2. Legal Status (CBD & THC)
      • 3.2.11.3. Regulatory Bodies Involved
    • 3.2.12. Uruguay
      • 3.2.12.1. Cultivation/Production
      • 3.2.12.2. Legal Status (CBD & THC)
      • 3.2.12.3. Regulatory Bodies Involved
    • 3.2.13. Colombia
      • 3.2.13.1. Cultivation/Production
      • 3.2.13.2. Legal Status (CBD & THC)
      • 3.2.13.3. Regulatory Bodies Involved
    • 3.2.14. Argentina
      • 3.2.14.1. Cultivation/Production
      • 3.2.14.2. Legal Status (CBD & THC)
      • 3.2.14.3. Regulatory Bodies Involved
    • 3.2.15. Chile
      • 3.2.15.1. Cultivation/Production
      • 3.2.15.2. Legal Status (CBD & THC)
      • 3.2.15.3. Regulatory Bodies Involved
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cannabidiol Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
  • 3.5. Import/Export Scenario, by Country
    • 3.5.1. U.S.
    • 3.5.2. Canada
    • 3.5.3. Germany
    • 3.5.4. Italy
    • 3.5.5. France
    • 3.5.6. Croatia
    • 3.5.7. Netherlands
    • 3.5.8. Czech Republic
    • 3.5.9. Poland
    • 3.5.10. Switzerland
    • 3.5.11. Uruguay
    • 3.5.12. Columbia
    • 3.5.13. Brazil
    • 3.5.14. Argentina
    • 3.5.15. Chile
    • 3.5.16. Australia
    • 3.5.17. China
    • 3.5.18. India
    • 3.5.19. Japan
    • 3.5.20. New Zealand
    • 3.5.21. South Korea

Chapter 4. Cannabidiol Market: Source Type Estimates & Trend Analysis

  • 4.1. Source Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Cannabidiol Market by Source Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Hemp
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Marijuana
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cannabidiol Market: Sales Type Estimates & Trend Analysis

  • 5.1. Sales Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Cannabidiol Market by Sales Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Business to Business (B2B)
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Business to Consumer (B2C)
      • 5.4.2.1. Hospital Pharmacies
      • 5.4.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.2. Online Stores
      • 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.2.3. Retail Stores
      • 5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cannabidiol Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Cannabidiol Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Medical
      • 6.4.1.1. Chronic Pain
      • 6.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.1.2. Mental Disorders
      • 6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.1.3. Cancer
      • 6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.1.4. Others
      • 6.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Personal Use
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Pharmaceutical
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Wellness
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.4.2. Food & Beverages
      • 6.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.4.3. Personal Care & Cosmetics
      • 6.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.4.4. Nutraceuticals
      • 6.4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.4.4.5. Others
      • 6.4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD million)

Chapter 7. Cannabidiol Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Switzerland
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. The Netherlands
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Poland
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Czech Republic
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Croatia
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. New Zealand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Colombia
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Uruguay
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.6. Chile
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Regulatory framework
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Israel
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. ENDOCA
      • 8.3.1.1. Company news
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Cannoid, LLC
      • 8.3.2.1. Company news
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Medical Marijuana, Inc.
      • 8.3.3.1. Company news
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Folium Europe B.V.
      • 8.3.4.1. Company news
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Canopy Growth Corporation
      • 8.3.5.1. Company news
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Elixinol
      • 8.3.6.1. Company news
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. NuLeaf Naturals, LLC
      • 8.3.7.1. Company news
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Isodiol International, Inc.
      • 8.3.8.1. Company news
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. PharmaHemp
      • 8.3.9.1. Company news
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. The Cronos Group
      • 8.3.10.1. Company news
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives